Page last updated: 2024-12-08

hinesol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

hinesol: from Atractylodes Lance rhizome; RN given refers to (2R-(2alpha,5alpha(S*)))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AtractylodesgenusA plant genus of the family ASTERACEAE. Members contain hinesol and atractylon. Atractylodes rhizome is Byaku-jutsu. A. lancea rhizome is So-jutsu.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID10059437
SCHEMBL ID2033966
MeSH IDM0180923

Synonyms (8)

Synonym
hinesol
icwhtqrtthcuhw-ipypfgdcsa-
inchi=1/c15h26o/c1-11-6-5-7-12(2)15(11)9-8-13(10-15)14(3,4)16/h6,12-13,16h,5,7-10h2,1-4h3/t12-,13+,15+/m1/s1
SCHEMBL2033966
2-(6,10-dimethylspiro[4.5]dec-6-en-2-yl)-2-propanol #
ICWHTQRTTHCUHW-IPYPFGDCSA-N
(2s,5r,10r)-alpha,alpha,6,10-tetramethylspiro[4.5]dec-6-ene-2-methanol
2-[(3s,5r,6r)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (20.00)18.2507
2000's7 (35.00)29.6817
2010's7 (35.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]